Loading
Life sciences · Journal article
Ukrainian Journal of Cardiology · October 30, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Obesity and hypertension frequently coexist and together increase cardiovascular disease (CVD) risk through interrelated endocrine, inflammatory, and vascular pathways. The aim – evaluated selected biochemical, thyroid, inflammatory, and genetic markers, with a particular focus on angiotensin-converting enzyme (ACE) gene expression, in individuals with obesity-associated hypertension.Materials and methods. A case-control design was used, including 360 participants (180 hypertensive-obese cases and 180 normotensive controls). Fasting blood samples were analyzed for thyroid-stimulating hormone (TSH), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and ACE gene expression quantified using the 2–ΔΔCt method, along with routine metabolic, renal, and cardiac parameters. Group differences were assessed using non-parametric tests. Receiver operating characteristic (ROC) curves were constructed to evaluate diagnostic performance, and multivariable logistic regression was applied to identify independent predictors of obesity-related hypertension. Correlation and linear regression analyses were used to examine factors influencing ACE gene expression.Results. Individuals with hypertensive obesity showed significantly higher levels of TSH, hs-CRP, IL-6, and ACE gene expression compared with controls. ACE gene expression demonstrated the greatest discriminatory ability on ROC analysis (AUC 0.86). Significant positive correlations were observed between ACE gene expression and both hs-CRP and IL-6. In regression analysis, ACE gene expression, hs-CRP, and IL-6 emerged as independent predictors, with ACE gene expression showing the strongest association.Conclusions. Obesity-hypertension is characterized by heightened inflammatory activity, endocrine alterations, and increased ACE gene expression. ACE gene expression may have potential value for identifying individuals at elevated cardiometabolic risk, although further longitudinal studies are needed to confirm its clinical relevance.